Kalb Michael Wayne 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Kalb Michael Wayne
Executive Vice President & CFO
Transactions
- Tax Payment
Common Stock, par value $0.001 per share
2025-01-02−2,941→ 4,197 total - Exercise/Conversion
Common Stock, par value $0.001 per share
2025-01-02+7,138→ 7,138 total - Exercise/Conversion
Restricted Stock Units
2025-01-02−7,138→ 475,699 total→ Common Stock (7,138 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/5th each on January 1, 2025, 2026, 2027, 2028 and 2029.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on January 2, 2025.